Navigation Links
Hospira Names Matthew R. Stober Senior Vice President of Operations
Date:4/15/2013

LAKE FOREST, Ill., April 15, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, announced that Matthew R. (Matt) Stober has been named senior vice president, Operations, effective today. In addition to expanding his current U.S. responsibilities to assume leadership for all of Hospira's pharmaceutical manufacturing operations, Mr. Stober will have responsibility for the operations functions, including manufacturing science and technology, engineering, competitive strategy, health and safety, supply chain and procurement. Mr. Stober succeeds John B. Elliot , who has led the Operations organization since April 2012 and will provide continuity of support until his retirement at the end of the year. Both Mr. Elliot and Mr. Stober will serve as members of the company's senior leadership team, led by F. Michael Ball , chief executive officer.

"Matt brings the perfect blend of vision and experience to our operations organization, backed by a proven track record of success at Hospira," said Mr. Ball. "In his expanded role, we're confident Matt will continue to successfully advance our dual commitment to remediate and modernize our processes and operations while delivering patient-critical products, and ultimately establish our manufacturing operations as a strategic, competitive advantage. We thank John for his strong counsel and continued support during the transition and look forward to Matt's many additional contributions."  

Mr. Stober, 45, joined Hospira in 2011 as its corporate vice president, U.S. Pharma Operations, where he has held primary responsibility for Hospira's Rocky Mount, N.C.; McPherson, Kan.; Austin, Texas; and Clayton, N.C., facilities, along with global engineering and program management. In 2012, he supported Hospira's efforts to produce and deliver more than half a billion units that were on the U.S. Food and Drug Administration (FDA) drug shortage list to help alleviate the industry-wide shortage for critical generic injectable drugs.

He joined Hospira from Johnson & Johnson, where he served as the vice president and global platform leader for solids, parenterals and vaccines. Mr. Stober has extensive experience managing transformational change in business-critical settings, as well as leading global and multi-company development projects, new product launches and large-scale organizational transformations. He has been in the pharmaceutical industry for nearly 25 years, having held significant leadership roles at Novartis Vaccines and Diagnostics, GlaxoSmithKline and Merck.

Born in Connecticut, Mr. Stober earned his Bachelor of Science degree in chemical engineering from Villanova University.

About Hospira
Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 16,000 employees. Learn more at www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Hospira to Host Conference Call for First-Quarter 2013 Results
2. Hospira Announces Executive Changes
3. Hospira Reports Fourth-Quarter and Full-Year 2012 Results
4. Hospira to Present at Upcoming Investor Conferences
5. Hospira and Q Core Medical Sign International Distribution Agreement for Sapphire Infusion System
6. Hospira to Present at the J.P. Morgan 31st Annual Healthcare Conference Jan. 8, 2013
7. Hospira Reports Third-Quarter 2012 Results
8. Hospira to Acquire Active Pharmaceutical Ingredient Manufacturing and R&D Facilities
9. Hospira Reports Second-Quarter 2012 Results
10. Hospira Expands Board of Directors With Election of Dennis M. Fenton
11. Hospira to Host Conference Call for Second-quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2020)... ... 2020 , ... Cano Health, LLC, a leading population health ... Antonio is happy to announce that it has selected Tejano musician Jay Perez ... will serve as community advisor, advertising talent, and creative consultant for Cano Health, ...
(Date:8/28/2020)... , ... August 28, 2020 , ... ... and aesthetic beauty, bringing a unique perspective and approach. Armed with her qualifications ... ventured out to share her knowledge of the human body with the nation ...
(Date:8/27/2020)... ... August 27, 2020 , ... Austin Oral Surgery – an oral and maxillofacial ... David Szalay, DDS, MD, has joined the practice. An accomplished oral and maxillofacial surgeon, ... which is scheduled to open this fall. The new office is slated for 1601 ...
Breaking Medicine Technology:
(Date:9/3/2020)... ... September 03, 2020 , ... The growing adoption of ... Fall 2020 Virtual Conference, a two-day virtual event for radiology professionals that will ... is the follow-up to AuntMinnie.com's successful virtual event in spring 2020, in which ...
(Date:9/1/2020)... Calif. (PRWEB) , ... September 01, 2020 , ... ... a new practice in Glendale. While the office will be the ... as breast augmentation, tummy tucks, buttock augmentation (Brazilian butt lift), as well as ...
(Date:8/31/2020)... ... , ... Cardiothoracic surgeons at Allegheny General Hospital (AGH), part ... (CMU) to develop a new heart monitoring device designed to serve as an ... AGH/CMU team was recently awarded a “Trailblazer” grant from the National Institutes of ...
(Date:8/31/2020)... ... August 31, 2020 , ... Genesis Chiropractic Software ... today the launch of its integrated, HIPAA compliant, telehealth solution, available to US-based ... in under 90 seconds. , According to the U.S. Department of Health ...
(Date:8/31/2020)... ... August 31, 2020 , ... In an effort to give ... is donating 10 percent of each hotel room booked with a special new rate ... & Northwest Indiana (RMHC-CNI) , effective immediately. Donations will be applied to any ...
Breaking Medicine News(10 mins):